Recent outbreaks of Zika virus (ZIKV) have been associated with birth defects, 21 including microcephaly and neurological impairment. However, the mechanisms which 22 confer increased susceptibility to ZIKV during pregnancy remain unclear. We 23 hypothesized that poor outcomes from ZIKV infection during pregnancy are due in part 24 to pregnancy-induced alteration of innate immune cell frequencies and cytokine 25 expression. To examine the impact of pregnancy on innate immune responses, we 26 inoculated pregnant and non-pregnant female C57BL/6 mice with 5x105 FFU of ZIKV 27 intravaginally. Innate immune cell frequencies and cytokine expression were measured 28 by flow cytometry at day 3 post infection. Compared to non-pregnant mice, pregnant 29 mice exhibited higher frequencies of uterine macrophages (CD68+) and tolerogenic 30 dendritic cells (CD11c+ CD103+ and CD11c+ CD11b+). Additionally, ZIKV-infected 31 pregnant mice had lower frequencies of CD45+ IL-12+ and CD11b+ IL-12+ cells in the 32 uterus and spleen. These data show that pregnancy results in an altered innate immune 33 response to ZIKV infection in the genital tract of mice and that pregnancy-associated 34 immune modulation may play an important role in the severity of acute ZIKV infection.
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differ between the pregnant and non-pregnant mice. ZIKV PCR from vaginal washes at 141 days 1, 2, and 3 post-infection revealed peak values at day 2 post-infection, and ZIKV 142 RNA was not detected in fetal tissues at day 3 or 6 post-infection (data not shown). The 143 weights of the mice did not change significantly during infection (data not shown), and 144 the numbers of fetuses in both the mock and ZIKV-infected pregnant mice were similar 145 (Fig. 1C) . CD11b (expressed on monocytes, macrophages, and DCs), CD11c (expressed on DCs, 155 monocytes, macrophages, and granulocytes), Ly6C (expressed on macrophages, 156 monocytes, and neutrophils), and CD103 (expressed on certain DC subsets). In the 157 splenic tissue, ZIKV infection during pregnancy resulted in a significantly increased 158 frequency of CD45+ CD68+ macrophages compared to ZIKV-infected non-pregnant 159 mice ( Fig. 2A, p= 0 .0095, ANOVA=0.0107). There was no significant difference in the 160 frequency of CD45+ CD68+ macrophages between the mock-inoculated pregnant and 
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Similar to CD11b+ CD11c+ cells, we found that ZIKV-inoculated, pregnant mice 234 exhibited a significant increase in frequency of uterine CD11c+ CD103+ cells ( Fig. 5A , 235 p= 0.0004 ZIKV non-pregnant vs. ZIKV pregnant, ANOVA= 0.0001). ZIKV infection in 236 non-pregnant mice resulted in a suppression of this tolerogenic cell population but 237 pregnant mice still exhibited high levels of CD11c+ CD103+ cells despite ZIKV infection.
238
Within the CD11c+ CD103+ population, there was no significant change in the CD86+ 239 (ANOVA=0.2347) or IL-10+ (ANOVA=0.7101) subpopulations between treatment 240 groups ( Fig. 5B&C) . In the spleen, there were no significant differences in the 241 frequencies of CD11c+ CD103+ (ANOVA=0.3143) or CD11c+ CD103+ CD86+ 242 (ANOVA=0.895) cells between groups (Fig. 5D) . These data show that local factors Additionally, multiple studies have shown that IL-12 levels are increased in the blood 251 and endometrial tissue of in women with recurrent pregnancy loss, suggesting that IL-12 252 may be detrimental during pregnancy (43, 44) . In uterine tissue at day 3 post-infection, 253 13 we found that the frequency of CD45+ cells producing IL-12 was decreased following 254 ZIKV infection in pregnant compared to non-pregnant mice (Fig. 6A, p=0 .0081, 255 ANOVA= 0.007). This difference was not seen when non-pregnant and pregnant mock-256 infected mice were compared (p=0.9535). Next, we further analyzed IL-12 expression in 257 several immune cell subtypes. We found that IL-12+ CD11b+ (Fig. 6B, p=0 .007, 258 ANOVA= 0.0059), IL-12+ CD68+ (Fig. 6C, p=0 .0018, ANOVA= 0.0011), and IL-12+ 259 Ly6C+ (Fig. 6E, p=0 .004, ANOVA= 0.0028) cells were significantly decreased in ZIKV-260 infected, pregnant mice compared to ZIKV-infected non-pregnant mice. CD45+ CD103+ 261 cells exhibited a trend towards decreased IL-12 expression during pregnancy in both 262 mock and ZIKV-infected mice when compared to non-pregnant mice (ANOVA= 0.006) 263 ( Fig. 6D) . There was no significant difference in CD11c+ IL-12+ cells between groups 264 (data not shown, ANOVA=0.1943).
265
Additionally, we measured the frequencies of IL-6+ cells within each of these 266 populations, as it has been reported that IL-6 is upregulated during ZIKV infection (45). 267 We found no significant differences in the frequencies of IL-6+ CD45+, IL-6+ CD68+, IL-268 6+ CD11b+, IL-6+ CD11c+, IL-6+ Ly6C+, or IL-6+ CD103+ cells between groups ( in IL-12 expression. We found a significant decrease in splenic CD45+ IL-12+ cells in 277 pregnant ZIKV-infected mice compared to non-pregnant ZIKV-infected mice (Fig. 7A,   278 p=0.0323, ANOVA=0.0288). In the subset analysis, we found that frequencies of IL-12+ 279 cells were significantly decreased within the CD68+ (Fig. 7B, p=0 .0441, 280 ANOVA=0.0241) and CD11b+ (Fig. 7C, p=0 .0093, ANOVA=0.0107) populations in 281 ZIKV-infected pregnant mice compared to ZIKV-infected non-pregnant mice. Similar to 282 the uterus, inhibition of IL-12 expression appeared to be specific to monocytes and 283 macrophages, as CD11c+ (Fig. 7D, ANOVA=0 .2629) and CD103+ (Fig. 7F,   284 ANOVA=0.9808) cells did not exhibit significant changes in IL-12 expression between 285 treatment groups. The frequency of Ly6C+ IL-12+ cells trended toward a decrease in 286 the ZIKV-infected pregnant mice compared to the other groups, but this change did not 287 reach significance when the groups were compared to each other (Fig. 7E,   288 ANOVA=0.0478). Similar to the results seen in the uterus, IL-6 expression did not differ 289 significantly in any of the cell subsets tested (Fig. 7G&H) . inflammation during early implantation likely as a mechanism to protect the developing 308 fetus. 309 We also found that some of the inhibitory cell phenotypes were specific to the 310 uterine tissue. For example, during acute ZIKV infection, non-pregnant mice significantly 311 suppress immunotolerant CD11c+CD103+ cells to support acute inflammation for the 312 infection; however, pregnant mice exhibit a significant increase in CD11c+CD103+ cells 313 in the uterus. These changes were not seen in the spleen implying that the expression 314 of CD11c+CD103+ cells in the uterus is regionally regulated to support the developing 315 pregnancy.
316
In contrast, some of the inhibitory cell phenotypes were found in both the uterus 317 and the spleen. We found that CD45+IL-12 responses to acute viral infection were 318 significantly decreased in both the uterus and spleen of pregnant mice compared to 319 non-pregnant mice. In the uterus, decreased IL-12 production was largely due to 320 CD11b+, CD68+, and Ly6C+ cells, and in the spleen decreased IL-12 production was 321 16 largely due to CD11b+ cells. These data show for the first time, that both systemic and 322 regional responses during pregnancy modulate the acute, innate immune cellular 323 response to acute viral infection.
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In our mouse model, implantation occurs at E4 (46), and we inoculated mice 
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Our data also show that uterine monocytes, macrophages, and DCs are deficient 369 in IL-12 production upon challenge with ZIKV during pregnancy. Since IL-12 is an 370 important activator of NK cell responses(60), suppression of IL-12-induced activation of 371 uterine NK cells is likely important to prevent NK activation and increased risk to the 372 pregnancy. Our data show that virus-induced production of IL-12 by CD45+ cells is 373 significantly reduced in pregnant mice compared to non-pregnant mice. This may be an 374 important mechanism by which the localized immune response in the decidua is 375 modulated to protect the pregnancy while still mounting an immune response to viral 376 infection that is efficacious but not deleterious to the developing fetus. These findings 377 should be evaluated as a potential biomarker of pregnancy loss during acute infection, 378 as these markers may provide prognostic value for pregnancy loss and complications.
379
The findings of this study may be broadly applicable to other acute infections 380 during pregnancy, and further studies are needed to evaluate pregnancy-induced 381 immune modulation during acute infection and vaccination. Additionally, our data show 382 that activation of important antigen presenting cells are modulated during pregnancy.. 
